Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Buy
129,518
+46,653
+56% +$5.65M 0.01% 470
2026
Q1
$13.6M Buy
82,865
+23,313
+39% +$3.58M 0.01% 445
2025
Q4
$10.4M Buy
+59,552
New +$10.9M 0.01% 500
2023
Q4
Sell
-74,557
Closed -$1.88M 713
2023
Q3
$1.88M Sell
74,557
-18,000
-19% -$412K ﹤0.01% 593
2023
Q2
$1.95M Sell
92,557
-28,700
-24% -$545K ﹤0.01% 594
2023
Q1
$2.07M Hold
121,257
﹤0.01% 587
2022
Q4
$2.42M Hold
121,257
0.01% 575
2022
Q3
$2.61M Hold
121,257
0.01% 569
2022
Q2
$2.39M Hold
121,257
0.01% 583
2022
Q1
$2.85M Buy
121,257
+19,157
+19% +$445K 0.01% 594
2021
Q4
$2.79M Hold
102,100
﹤0.01% 616
2021
Q3
$2.81M Hold
102,100
0.01% 607
2021
Q2
$2.91M Hold
102,100
0.01% 614
2021
Q1
$3.48M Buy
+102,100
New +$3.9M 0.01% 591

Other funds holding INSM

Swedbank's INSM Position: Q2 2026 in Review

Swedbank increased its Insmed (INSM) stake by 56% in Q2 2026, buying an estimated $5.65M and bringing the position to 129,518 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #470.

Swedbank first reported a position in INSM in Q1 2021 and has held it in 14 quarters since. 161 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Swedbank held 129,518 shares of Insmed worth $13.8M as of Q2 2026.
  • Swedbank bought 46,653 Insmed shares in Q2 2026, an estimated $5.65M.
  • Insmed made up 0.01% of Swedbank's portfolio in Q2 2026, its #470 holding.
  • Swedbank first reported a position in Insmed in Q1 2021 and has held it in 14 quarters since.
  • 161 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.